These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 10037372

  • 1. The impact of primary stage on survival in patients with lymph node positive bladder cancer.
    Vieweg J, Gschwend JE, Herr HW, Fair WR.
    J Urol; 1999 Jan; 161(1):72-6. PubMed ID: 10037372
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
    Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE.
    J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E, Stöter E, van Ophoven A, Bierer S, Bolenz C, Hertle L, Wülfing C.
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [Abstract] [Full Text] [Related]

  • 6. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Jul; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 7. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 8. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE.
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 12. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
    Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y.
    Eur Urol; 2007 Jan; 51(1):137-49; discussion 149-51. PubMed ID: 16793197
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS.
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [Abstract] [Full Text] [Related]

  • 14. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP.
    Urol Oncol; 2006 Aug; 24(4):349-55. PubMed ID: 16818190
    [Abstract] [Full Text] [Related]

  • 15. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL, Lin DW, Porter MP.
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [Abstract] [Full Text] [Related]

  • 16. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
    Herr HW, Donat SM.
    J Urol; 2001 Jan; 165(1):62-4; discussion 64. PubMed ID: 11125364
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer.
    Nagele U, Anastasiadis AG, Merseburger AS, Sievert KD, Stenzl A, Kuczyk M.
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):871-6. PubMed ID: 16761930
    [Abstract] [Full Text] [Related]

  • 18. Superiority of ratio based lymph node staging for bladder cancer.
    Herr HW.
    J Urol; 2003 Mar; 169(3):943-5. PubMed ID: 12576818
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP.
    J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [Abstract] [Full Text] [Related]

  • 20. Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer.
    Shirotake S, Kikuchi E, Matsumoto K, Yazawa S, Kosaka T, Miyajima A, Nakagawa K, Oya M.
    Jpn J Clin Oncol; 2010 Mar; 40(3):247-51. PubMed ID: 19887521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.